Recombinant Anti-CD19 x Anti-CD28 Bispecific Antibody (F(ab')2-scFv2) is designed to be expressed as two chains combined via a hinge region. The scFv of the anti-CD19 specificity is fused to the C terminus of the anti-CD28 Fab fragment, or vice versa. This format comprises four binding sites (two same scFv regions and two same Fab fragments), two for each antigen. This BsAb can retarget T cells to tumor cells. It is designed for the research of B cell lymphoma; Follicular lymphoma; Leukemia therapy.
There are currently no customer reviews or questions for Recombinant Human Anti-CD19 x Human Anti-CD28 Bispecific Antibody (F(ab')2-scFv2) (BABFV-H217). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS